Sri Trang Gloves (Thailand) Public Company Limited
SET:STGT-R Stock Report
Market Cap: ฿30.9b
Sri Trang Gloves (Thailand) Valuation
Is STGT-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of STGT-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: STGT-R (THB10.8) is trading above our estimate of fair value (THB3.32)
Significantly Below Fair Value: STGT-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for STGT-R?
Key metric: As STGT-R is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for STGT-R. This is calculated by dividing STGT-R's market cap by their current
earnings.
What is STGT-R's PE Ratio?
PE Ratio
78.1x
Earnings
฿396.37m
Market Cap
฿30.94b
STGT-R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: STGT-R is expensive based on its Price-To-Earnings Ratio (78.1x) compared to the Asian Medical Equipment industry average (25.9x).
Price to Earnings Ratio vs Fair Ratio
What is STGT-R's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
STGT-R PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
78.1x
Fair PE Ratio
62.1x
Price-To-Earnings vs Fair Ratio: STGT-R is expensive based on its Price-To-Earnings Ratio (78.1x) compared to the estimated Fair Price-To-Earnings Ratio (62.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.